Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Germany to ban therapeutic cloning "for now":

This article was originally published in Clinica

Executive Summary

Germany's national ethics council this week decide that cloning for research purposes must be put on hold for the present. However, 12 of the council's 25 members still believe that therapeutic cloning could be ethically defended and so the agreement represents a compromise after a year-long debate on the subject. Although only five members wanted a blanket ban on all forms of cloning, the compromise still represents a blow to tissue engineering companies in Germany, who were aiming to press ahead with harvesting stem cells from therapeutic clones. Research minister Edelgard Buhlman welcomed the council's ruling and said: "At this point we do not see any reason to alter the existing ban contained in the embryo protection law."

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT059564

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel